Search
Edwards Lifesciences Corp
EWAdd to Watchlist
89.135USD
+0.735+0.83%
Market hours 10/22, 13:22（ET）
51.32BMarket Cap
47.34P/E TTM
Edwards Lifesciences Corp (EW) Stock Price Target & Forecast
Analyst Rating
Based on 31 analysts giving stock ratings to Edwards Lifesciences Corp in the past month.
Buy
10 Strong Buy
15 Buy
6 Hold
0 Sell
0 Strong Sell
Target Price
99.603USD+15.01%
EW Analyst Recommendation Trends
In the current month, EW has received 15 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. EW average Analyst price target in the last month is 99.603.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
10
10
10
9
9
9
8
8
15
15
13
14
15
16
16
16
6
6
9
11
10
10
11
11
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
31
31
32
34
34
35
35
35
EW Analyst Rating for Peer Comparison
Updated: Oct 20, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Intuitive Surgical Inc
ISRG
11
14
9
1
0
35
Boston Scientific Corp
BSX
9
17
8
0
0
34
Thermo Fisher Scientific Inc
TMO
11
16
4
0
0
31
Veeva Systems Inc
VEEV
8
14
7
1
0
30
Danaher Corp
DHR
11
13
3
0
0
27
Waters Corp
WAT
8
10
8
0
0
26
GE Healthcare Technologies Inc
GEHC
6
10
7
0
0
23
Resmed Inc
RMD
3
8
10
1
1
23
Agilent Technologies Inc
A
6
10
7
0
0
23
Illumina Inc
ILMN
5
6
8
2
1
22
Financial Forecasting
Based on analysts' estimates, EW EPS is projected to reach 0.737 in FY2026Q3, following reported EPS of 0.420 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
0.62
0.73
0.74
0.74
0.71
Actual
0.16
0.66
0.42
--
--
Surprise
-74.57%
-9.59%
-43.33%
--
--
FAQs
What is Edwards Lifesciences Corp's expected revenue for the next quarter?
Edwards Lifesciences Corp's expected revenue is 1.68B.
What is Edwards Lifesciences Corp's price target?
Analysts forecast that Edwards Lifesciences Corp's price target is USD 99.60, with the highest forecast at USD 110.00 and the lowest forecast at USD 85.00.
How have Edwards Lifesciences CorpEW's recent earnings per share performed?
The market expectation was USD 0.42, while Edwards Lifesciences CorpEW's earnings per share (EPS) for the previous quarter was USD 0.66. EPS for the next quarter is expected at USD 0.74.
What is the analyst rating for Edwards Lifesciences Corp?
Based on the ratings of Edwards Lifesciences Corp's stock from 31 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.